Literature DB >> 31553772

Correction: SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience.

Alessandra Mangia, Valeria Piazzolla, Anna Giannelli, Egidio Visaggi, Nicola Minerva, Vincenzo Palmieri, Immacolata Carraturo, Domenico Potenza, Nicola Napoli, Gianfranco Lauletta, Vincenzo Tagarielli, Rosanna Santoro, Ernesto Piccigallo, Sergio De Gioia, Angelo Chimenti, Giuseppe Cuccorese, Antonio Metrangolo, Michele Mazzola, Ernesto Agostinacchio, Giuseppe Mennea, Carlo Sabbà, Marina Cela, Massimiliano Copetti, Ruggiero Losappio.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0215783.].

Entities:  

Year:  2019        PMID： 31553772      PMCID： PMC6760782          DOI： 10.1371/journal.pone.0223287

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


In the SVR, co-morbidities and concomitant medication subsection of the Results, there is an error in the 15th sentence of the first paragraph. The correct sentence is: Among PWID, 35% of patients were taking different antipsychotics or anesthetics to treat chronic pain as analgesics (10 olanzepine, 15 haloperidol and 21 ketamine).
  1 in total

1.  SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience.

Authors:  Alessandra Mangia; Valeria Piazzolla; Anna Giannelli; Egidio Visaggi; Nicola Minerva; Vincenzo Palmieri; Immacolata Carraturo; Domenico Potenza; Nicola Napoli; Gianfranco Lauletta; Vincenzo Tagarielli; Rosanna Santoro; Ernesto Piccigallo; Sergio De Gioia; Angelo Chimenti; Giuseppe Cuccorese; Antonio Metrangolo; Michele Mazzola; Ernesto Agostinacchio; Giuseppe Mennea; Carlo Sabbà; Marina Cela; Massimiliano Copetti; Ruggiero Losappio
Journal:  PLoS One       Date:  2019-05-15       Impact factor: 3.240
  1 in total
  1 in total

1.  Sofosbuvir/velpatasvir in treatment-experienced HCV-infected patients - short report.

Authors:  Anna Piekarska; Aleksandra Berkan-Kawińska; Zbigniew Deroń; Justyna Ciupińska; Jolanta Białkowska
Journal:  Clin Exp Hepatol       Date:  2020-02-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.